ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HCM Hutchmed (china) Limited

287.00
-17.00 (-5.59%)
Last Updated: 15:53:33
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -17.00 -5.59% 287.00 283.00 289.00 312.00 287.00 312.00 77,420 15:53:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 304p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 751 to 774 of 4100 messages
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
26/1/2016
16:35
It will be interesting to see what happens to Beigene's $100m IPO that's scheduled for the 4th Feb. They have a tiny pipeline and if they can get it away there's nothing at the moment to suggest our IPO will not be successful
nerdofsteel
26/1/2016
15:34
You might well be right.Its the most logical explanation.
steeplejack
26/1/2016
15:31
As I mentioned above, I'm pretty sure this is down to the fact the IPO might not now go ahead, plus the fact that it's bloody illiquid.
liam1om
26/1/2016
15:12
Thanks might be
nw99
26/1/2016
14:27
It has fallen heavily on low volumes. It appears technical. Slater Growth is a big holder of this stock.
d40eq6
26/1/2016
14:10
No smoke without fire
nw99
26/1/2016
14:07
Strong support at £10
nw99
26/1/2016
14:07
Looks awful and its Chinese
nw99
26/1/2016
14:06
It's purely technical. It broke 25 pounds and dropped in a vacuum to long term solid buying today
montynj
26/1/2016
13:56
No. There was a piece on Bloomberg earlier about how the biotech sector faces increased volatility and a number of IPO's may be pulled.
liam1om
26/1/2016
13:45
Massive drop!!Are we missing any fudging in account ? These are Chinese companies..
neurolodger
26/1/2016
13:39
This really is wholly unexpected USAListing delay?
nfs
26/1/2016
13:34
Any reason for the massive drop?
hamsterdam
26/1/2016
13:07
Wiped out here loss cut
nw99
26/1/2016
11:27
Eeeeerrrrr....

aren't you missing a zero off Beigene's IPO price?

Why the massive drop here? Comforting that it's on such tiny volume I suppose.

nahoon
25/1/2016
12:58
Beigene's IPO now priced and ready to go $10m
Small Company with a very small pipeline

HCM IPO nearly ready to go $100m
Big Company with a very large, broad and deep pipeline

nerdofsteel
24/12/2015
08:35
NASDAQ IPO $100m due to complete in Jan
Phase III drug study commenced
Big property compensation recently announced
Further drug pipeline milestone payments received and more due

nerdofsteel
23/12/2015
11:39
any reason for this going up recently?
jayson26jay
01/12/2015
16:42
great find thankyou! I notice Beigene's NASDAQ IPO for $100m, running in parallel to our own, and I'm interested to see how well that goes...
nerdofsteel
01/12/2015
13:01
This looks interesting - helps the long term picture;
sspurt
30/11/2015
19:03
no but there is a huge list due

NASDAQ listing
Shanghai Property compensation and sale circa $90m proceeds
Multiple drug pipeline updates

nerdofsteel
30/11/2015
16:33
Big rise at the close, any news?
ouiey1000
23/11/2015
15:09
thanks miti - I will do that. I am assuming our IPO will be completed by year end and also assume we may raise more than $100m.....
nerdofsteel
13/11/2015
17:26
revised filing with the SEC, all moving along swiftly

I bet the bookrunners have A LOT of interest from their institutional Clients

There;s nothing the Americans like more than a Biopharma with a big drug pipeline, existing revs and some big Breakthrough candidates. We will have a further masive re-rating inb the next year IMO

nerdofsteel
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older

Your Recent History

Delayed Upgrade Clock